← Leaderboards
Robert B Wilson
University Of Pennsylvania
$8,097,885
Attributed
$8,097,885
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,097,885 · 14
By mechanism
R01$4,532,313 · 3
R21$3,047,422 · 7
R29$358,900 · 1
R03$79,250 · 1
U13$45,000 · 1
R13$35,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Roger A Greenberg$15,375,785
- Steven S Scherer$10,278,132
- Walter R.t. Witschey$8,933,628
- Zhixun Dou$6,206,048
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenesGene ExpressionBaseProteinsFibroblastsLibrariesMitochondriaFrataxinScreening ProcedureFriedreich AtaxiaGene MutationSaccharomyces CerevisiaeProtein Structure FunctionGene TargetingNovel TherapeuticsRna InterferencePhenotypeDesignMitochondrial DysfunctionExhibitsPathway InteractionsPublic Health Medicine (Field)Affect
Grant awards (31)
p38 MAPK activation as a therapeutic target for Friedreich ataxia$556,671
R01 · FY2025 · NS · contact PI
p38 MAPK activation as a therapeutic target for Friedreich ataxia$557,469
R01 · FY2024 · NS · contact PI
p38 MAPK activation as a therapeutic target for Friedreich ataxia$587,412
R01 · FY2023 · NS · contact PI
Elucidation of contributions of telomere damage and non-cell autonomy to the pathophysiology of Friedreich ataxia using a zebrafish model$493,500
R21 · FY2023 · NS · contact PI
p38 MAPK activation as a therapeutic target for Friedreich ataxia$606,404
R01 · FY2022 · NS · contact PI
Drug and drug-target identification for mitochondrial diseases using random shRNA selection$484,000
R21 · FY2020 · NS · contact PI
Random shRNA Selection$385,915
R01 · FY2012 · GM · contact PI
Random shRNA Selection$385,915
R01 · FY2011 · GM · contact PI
Identification of Beta-Cell-Inducing Small RNAs by Random shRNA Selection$237,600
R21 · FY2011 · DK · contact PI
Random shRNA Selection$389,813
R01 · FY2010 · GM · contact PI
Identification of beta-cell-inducing small RNAs by random shRNA selection$199,688
R21 · FY2010 · DK · contact PI
Random shRNA Selection$385,125
R01 · FY2009 · GM · contact PI
RNAi therapeutics for Friedreich ataxia$236,250
R21 · FY2009 · NS · contact PI
RNAi therapeutics for Friedreich ataxia$196,875
R21 · FY2008 · NS · contact PI
Drug and drug target identification for Friedreich ataxia$78,750
R21 · FY2008 · NS · contact PI
Drug and Drug Target Identification for Friedreich's Ataxia$250,696
R21 · FY2007 · NS · contact PI
3rd International Friedreich's Ataxia Scientific Conference$35,000
R13 · FY2007 · NS · contact PI
Drug and drug target identification for Friedreich ataxia$176,625
R21 · FY2006 · NS · contact PI
Identification of Anticancer Drug Targets$225,863
R01 · FY2004 · CA
Friedreich Ataxia High Throughput Drug Screening Assays$188,219
R21 · FY2004 · NS
High throughput screen for cyclin D1 inhibitors (RMI)$79,250
R03 · FY2004 · NS
Identification of Anticancer Drug Targets$225,863
R01 · FY2003 · CA
Friedreich Ataxia High Throughput Drug Screening Assays$188,219
R21 · FY2003 · NS
Friedreich's Ataxia Research Conference$45,000
U13 · FY2003 · NS
Identification of Anticancer Drug Targets$225,863
R01 · FY2002 · CA
FUNCTIONAL STUDIES OF THE FRIEDREICHS ATAXIA PROTEIN$111,300
R29 · FY2002 · NS
IDENTIFICATION OF ANTICANCER DRUG TARGETS USING YEAST$158,500
R21 · FY2001 · CA
FUNCTIONAL STUDIES OF THE FRIEDREICHS ATAXIA PROTEIN$111,300
R29 · FY2001 · NS
IDENTIFICATION OF ANTICANCER DRUG TARGETS USING YEAST$158,500
R21 · FY2000 · CA
FUNCTIONAL STUDIES OF THE FRIEDREICHS ATAXIA PROTEIN$111,300
R29 · FY2000 · NS
FUNCTIONAL STUDIES OF THE FRIEDREICHS ATAXIA PROTEIN$25,000
R29 · FY2000 · NS